Through a Joint Partnership With Al Farabi Medical Laboratories, Dante Labs Brings Genomic Tests to the Kingdom Of Saudi Arabia

    Al Farabi Medical Laboratories is one of the most renowned medical labs in Saudi Arabia, with over 50 locations covering all regions. Dante Labs is a global leader in precision-based genomics and medicine. The two companies are happy to announce a partnership wherein they will offer patients in Saudi Arabia a wide range of clinical genomic tests, including Whole Genome Sequencing, Whole Exome Sequencing with interpretation, and Non-Invasive Prenatal Testing (NIPT). The partnership between the two companies was announced on November 9, 2022, via a joint press release. Both Andrea Riposati and Dr. Mohamed Marie have been quoted regarding the announcement.

    Andrea Riposati, who is both co-founder and CEO of Dante Labs, said that Dante Labs is thrilled to be able to offer advanced genomic testing services in partnership with Al Farabi Medical Labs of the Kingdom of Saudi Arabia. Riposati says, ”We are excited to support the growth of Al Farabi Medical Labs’ cutting-edge vision. Our combined mission is to create whole-genome sequencing-driven healthcare for individuals in Saudi Arabia, and we are delighted with this new partnership.

    Dr. Mohamed Marie is Al Farabi’s Founder and General Manager. He said, “Al Farabi Medical Laboratories is proud to incorporate Dante Labs technology in the Kingdom of Saudi Arabia. Al Farabi Medical Laboratories is a top medical laboratory with over 50 branches throughout the Kingdom. Dante Labs has been chosen as our partner for genetic testing and other genomic solutions. As we have in all other aspects of healthcare for the citizens of Saudi Arabia, we aim to provide the best quality services for our patients in genomics, supported by this new partnership with Dante Labs.

    More About Dante Labs

    Dante Labs, a global genomic company, is developing and commercializing a new category of transformative longevity and health applications based on whole-genome sequencing and AI. It uses its platform for better patient outcomes, personalized medicine, and enhanced diagnostics. The company has a large private genome database, one of the world’s largest, with consent for research. It also owns proprietary software that unleashes the power of genomic data at scale. Its proprietary processes enable industrial genomic sequencing, all of which will be leveraged by Al Farabi Medical Labs to provide genomic sequencing to citizens of Saudi Arabia, according to a recent press release.

    More About Al Farabi Medical Labs

    Since its founding, Al Farabi Medical Labs has maintained a policy of attracting, localizing, and using the latest diagnostic techniques to solve difficult medical problems using various diagnostic strategies. This includes speed of results, quality of work, and fair pricing. Al Farabi Medical Labs adheres to all international and local standards, as well as occupational safety and quality requirements. CBAHI and JCI accreditations have been awarded to the company as a result.